Mercado de medicamentos para el asma: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00021879
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 191
Buy Now

Se prevé que el mercado de medicamentos para el asma alcance los 34.136,10 millones de dólares en 2028 desde los 24.239,17 millones de dólares de 2021; se estima que crecerá a una tasa compuesta anual del 5,0 % durante 2021-2028.

El asma es una enfermedad pulmonar que afecta a personas de todas las edades. Produce sibilancias y dificulta la respiración. La exposición a una alergia o irritante, infecciones, ejercicio, estrés emocional y otras afecciones son posibles desencadenantes. Cuando los síntomas del asma se vuelven insoportables, se produce un ataque de asma. Los ataques pueden ocurrir de la nada y van desde leves hasta potencialmente mortales. El asma se controla con inhaladores de rescate para tratar los síntomas y con inhaladores controladores que previenen los síntomas. Los casos graves pueden requerir inhaladores de acción más prolongada que mantengan abiertas las vías respiratorias (formoterol, salmeterol, tiotropio) y esteroides inhalados. Los medicamentos para el asma vienen en varias formas, incluidas tabletas, inyecciones, líquidos e inhaladores, y se dividen en dos grupos, como broncodilatadores y antiinflamatorios.

El mercado de medicamentos para el asma está segmentado según la medicación. , vía de administración, canal de distribución y geografía. El mercado, según la geografía, está ampliamente segmentado en América del Norte, Europa, Asia Pacífico, Medio Oriente y Asia. África y el Sur y el Sur. Centroamérica. El informe de mercado de medicamentos para el asma ofrece información y un análisis en profundidad del mercado, enfatizando parámetros como el tamaño, las tendencias y la dinámica del mercado; avances tecnológicos en el mercado; y el análisis del panorama competitivo de los principales actores del mercado de medicamentos para el asma.

Perspectivas estratégicas

Algunos factores, como las crecientes implicaciones ambientales y el impacto ambiental. Se espera que las implicaciones genéticas de la contaminación del aire, la mayor vulnerabilidad en grupos étnicos específicos, la creciente exposición a partículas gruesas y la creciente prevalencia de trastornos fisiológicos que albergan asma tengan un impacto significativo a corto, mediano y largo plazo en el mercado de medicamentos para el asma en Estados Unidos. los próximos años. Sin embargo, las necesidades médicas insatisfechas y la falta de cumplimiento del tratamiento obstaculizan el crecimiento del mercado. El informe de mercado identifica oportunidades y tendencias futuras del mercado que pueden tener posibles impactos en el crecimiento del mercado.

regiones lucrativas en el mercado de medicamentos para el asma


Perspectivas del mercado
Crecientes implicaciones y consecuencias medioambientales Implicaciones genéticas de la contaminación del aire

El asma es una afección respiratoria crónica caracterizada por restricción fluctuante del flujo de aire, hiperreactividad bronquial e inflamación de las vías respiratorias. Según un artículo de revisión titulado "Impacto de la contaminación del aire en los resultados del asma" Según Tiotiu et.al., la contaminación del aire obstaculizó los resultados del asma en adultos y niños. La contaminación del aire provocada por el tráfico, el dióxido de nitrógeno (NO2) y el tabaquismo pasivo (SHS) son factores de riesgo importantes para el desarrollo de asma en los niños. Los síntomas del asma, las exacerbaciones y la disminución de la función pulmonar pueden desencadenarse por la exposición a la contaminación exterior.

En EE. UU., la exposición a la contaminación del aire sigue estando asociada con el asma. Esta afección respiratoria crónica, grave y potencialmente mortal, afecta la calidad de vida de más de ~23 millones de ciudadanos estadounidenses. La contaminación del aire puede agravar los síntomas del asma y provocar ataques de asma entre las personas. Los niños con asma, que afecta a aproximadamente 6 millones de niños en los EE. UU., son particularmente vulnerables a la contaminación.

Un nuevo estudio financiado por la Agencia de Protección Ambiental (EPA) analizó el vínculo entre la contaminación del aire y el asma. Si bien los expertos no pueden determinar cuál es el principal agente causante del asma debido a la contaminación del aire, la evidencia sugiere que suprime los genes que controlan el sistema inmunológico para distinguir entre un alérgeno y una sustancia extraña peligrosa, como un virus o una bacteria. Luego, el sistema inmunológico se acelera, desencadenando una reacción inflamatoria independientemente de si el fármaco es tóxico, lo que provoca asma.

Investigadores del Centro Infantil de la Universidad de Stanford investigaron el efecto de la contaminación del aire en dos genes implicados en la tolerancia inmunológica. en niños de una zona con altos niveles de contaminación. Descubrieron que la exposición a corto y largo plazo a altas cantidades de monóxido de carbono (CO), NO2 y PM2,5 (partículas) estaba relacionada con cambios en estos dos genes que causaban el asma. Estos hallazgos se centraron en los impactos epigenéticos de la exposición a la contaminación del aire y podrían ayudar en el desarrollo de medicamentos preventivos para el asma.

Cada una de estas investigaciones sobre el asma ha mejorado la comprensión del asma en niños y ha proporcionado información crucial a la EPA que Puede utilizarse para proteger la salud humana y el medio ambiente. A través de estos trabajos de investigación, se está acelerando el descubrimiento y desarrollo de fármacos para el asma, lo que está impulsando el mercado de medicamentos para el asma.

Perspectivas basadas en el tipo de medicamento

El mercado mundial de medicamentos para el asma, basado en medicamentos, se divide en medicamentos de alivio rápido y medicamentos de control a largo plazo. Se espera que el segmento de medicamentos de control a largo plazo tenga una mayor participación del mercado en los próximos años. Sin embargo, se espera que el segmento de medicamentos de alivio rápido registre una CAGR más alta durante el período de pronóstico.

Mercado de medicamentos para el asma, por medicamento: 2021 y 2028

Información basada en la ruta de administración

Según la ruta de administración, el mercado de medicamentos para el asma se segmenta en jeringas/viales inhalados y precargados, y otros. El segmento inhalado tuvo la mayor participación del mercado en 2021 y se espera que tenga una participación significativa durante el período de pronóstico. Sin embargo, se espera que el segmento de viales/jeringas precargadas registre la CAGR más alta de 2021 a 2028.

Información basada en el canal de distribución

Según el canal de distribución, el mercado de medicamentos para el asma está segmentado en farmacias en línea, farmacias hospitalarias y farmacias minoristas. Se espera que el segmento de farmacias minoristas tenga la mayor participación del mercado durante el período de pronóstico. Sin embargo, se espera que el segmento de farmacias en línea registre la CAGR más alta durante 2021-2028.

Varias empresas que operan en el mercado de medicamentos para el asma adoptan estrategias como lanzamientos de productos, fusiones y adquisiciones, colaboraciones, innovaciones de productos y ampliaciones de la cartera de productos para expandir su presencia en todo el mundo, mantener una marca y satisfacer las crecientes demandas de los consumidores. Algunos de los principales actores presentes en el mercado son AstraZeneca; Teva Pharmaceutical Industries Ltd.; GlaxoSmithKlinePLC; Boehringer Ingelheim International GmbH; Merck & Co., Inc.; Koninklijke Philips NV; Sanofi; Pfizer Inc.; Novartis AG; y Abbott.

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the asthma drugs?

Asthma is a lung disease that affects people of all ages. It produces wheezing and makes breathing difficult. Exposure to an allergy or irritant, infections, exercise, emotional stress, and other conditions are all potential triggers. When the symptoms of asthma become unbearable, an asthma attack ensues. Attacks can happen out of nowhere and range in severity from mild to life-threatening. Asthma is managed with rescue inhalers to treat symptoms and controller inhalers that prevent symptoms. Severe cases may require longer-acting inhalers that keep the airways open (formoterol, salmeterol, tiotropium), as well as inhalant steroids. Asthma drugs come in several forms, including tablets, injections, liquids, and inhalers; and it falls into two groups: bronchodilators and anti-inflammatories.

What are the driving factors for the asthma drugs market across the globe?

The global asthma drugs market is being driven by factors such as growing environmental implications & genetic implications of air pollution, more vulnerability in specific ethnic groups, growing exposure to coarse particulate matters, and the growing prevalence of physiological disorders harboring asthma.

What are the restraining factors for the asthma drugs market across the globe?

The unmet medical needs and the lack of treatment adherence are the leading restraints that will hinder the asthma drugs market growth.

Who are the major players in the market the asthma drugs market?

The asthma drugs market comprises of players that include AstraZeneca, TEVA PHARMACEUTICAL INDUSTRIES LTD, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Merck & Co., Inc, Koninklijke Philips N.V., Sanofi, Pfizer Inc., Novartis AG, and Abbott are among others.

Which segment is dominating the asthma drugs market by medication?

The asthma drugs market on the basis of medication is bifurcated into quick relief medications and long-term control medications. In 2021, the long-term control medications segment accounted for a larger share in the global asthma drugs market.

Which segment is expected to dominate the asthma drugs market by route of administration?

On the basis of route of administration, the asthma drugs market is segmented into inhaled, prefilled syringe/vials, and others. The inhaled segment is expected to hold the largest share from 2021 to 2028. However, the prefilled syringe/vials segment is expected to grow at the highest CAGR during the forecast period.

The List of Companies - Asthma Drugs Market

  1. AstraZeneca
  2. TEVA PHARMACEUTICAL INDUSTRIES LTD.
  3. GlaxoSmithKline plc
  4. Boehringer Ingelheim International GmbH
  5. Merck & Co., Inc.
  6. Koninklijke Philips NV
  7. Sanofi
  8. Pfizer Inc.
  9. Novartis AG
  10. Abbott

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports